H. Aggerbeck

发表

Immune response to diphtheria booster vaccine in the Baltic states.

T. Rønne, P. Ricks, A. Plesner, 2000, The Journal of infectious diseases.

Improved ELISA for determination of anti‐diphtheria and/or anti‐tetanus antitoxin antibodies in sera

H. Aggerbeck, I. Heron, M. Kristiansen, 1997, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Randomised Clinical Trial Investigating the Specificity of a Novel Skin Test (C-Tb) for Diagnosis of M. tuberculosis Infection

P. Andersen, S. Hoff, P. N. Tingskov, 2013, PloS one.

Sensitivity of C-Tb: a novel RD-1-specific skin test for the diagnosis of tuberculosis infection

K. Dheda, P. Andersen, J. Peter, 2015, European Respiratory Journal.

Double-blind randomized Phase I study comparing rdESAT-6 to tuberculin as skin test reagent in the diagnosis of tuberculosis infection.

P. Andersen, C. Prins, K. Weldingh, 2008, Tuberculosis.

Intranasal booster vaccination against diphtheria and tetanus in man.

S. Gizurarson, H. Aggerbeck, I. Heron, 1997, Vaccine.

Booster vaccination against diphtheria and tetanus in man. Comparison of calcium phosphate and aluminium hydroxide as adjuvants--II.

H. Aggerbeck, I. Heron, C. Fenger, 1995, Vaccine.

Specific Delayed-Type Hypersensitivity Responses to ESAT-6 Identify Tuberculosis-Infected Cattle

P. Andersen, I. Rosenkrands, J. McNair, 2003, Journal of Clinical Microbiology.

Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γ release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial.

J. Miro, A. Orcau, J. Caylà, 2017, The Lancet. Respiratory medicine.

Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon Î3 release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial

J. Miro, A. Orcau, J. Caylà, 2017 .

Simultaneous quantitation of diphtheria and tetanus antibodies by double antigen, time-resolved fluorescence immunoassay.

B. No̸rgaard-Pedersen, H. Aggerbeck, I. Heron, 1996, Journal of immunological methods.

Safety of ESAT-6.

S. Madsen, H. Aggerbeck, 2006, Tuberculosis.

Immunogenicity and safety of a tetravalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine.

S. Larsen, H. Aggerbeck, I. Heron, 1999, Scandinavian journal of infectious diseases.

Improvement of a Vero cell assay to determine diphtheria antitoxin content in sera.

H. Aggerbeck, I. Heron, 1991, Biologicals : journal of the International Association of Biological Standardization.

Detoxification of diphtheria and tetanus toxin with formaldehyde. Detection of protein conjugates.

H. Aggerbeck, I. Heron, 1992, Biologicals : journal of the International Association of Biological Standardization.

Evaluation of local toxicity after repeated intranasal vaccination 0 of guinea-pigs f E

H. Aggerbeck, Gudmundur, Sveinbjiirn, 2003 .

Booster vaccination against diphtheria and tetanus in man. Comparison of three different vaccine formulations--III.

H. Aggerbeck, I. Heron, J. Wantzin, 1996, Vaccine.

Alternatives to Animal Testing in the Quality Control of Immunobiologicals: Current Status and Future Prospects

Bart Rombaut, Klaus Cussler, Bernward Garthoff, 1994 .

European sero-epidemiology network: standardisation of the results of diphtheria antitoxin assays.

N. Andrews, C. von Hunolstein, R. Olander, 2000, Vaccine.

C-Tb skin test to diagnose Mycobacterium tuberculosis infection in children and HIV-infected adults: A phase 3 trial

A. Diacon, K. Dheda, P. Andersen, 2018, PloS one.

Intranasal vaccination against diphtheria and tetanus in human subjects

H. Valdimarsson, S. Gizurarson, F. Gudbrandsson, 1997 .

Intranasal vaccination against influenza using pharmaceutical excipients as immunological adjuvants

S. Gizurarson, H. Aggerbeck, I. Heron, 1996 .

Fall‐off in immunity following diphtheria revaccination ‐ an 8 year follow‐up study

O. Simonsen, H. Aggerbeck, I. Heron, 1996, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

First-in-Man Open Clinical Trial of a Combined rdESAT-6 and rCFP-10 Tuberculosis Specific Skin Test Reagent

P. Andersen, V. Thomsen, S. Hoff, 2010, PloS one.

Interaction between C-Tb and PPD given concomitantly in a split-body randomised controlled trial.

A. Diacon, K. Dheda, P. Andersen, 2019, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Adjuvanticity of aluminium hydroxide and calcium phosphate in diphtheria-tetanus vaccines--I.

H. Aggerbeck, I. Heron, 1995, Vaccine.

Risk of sensitization in healthy adults following repeated administration of rdESAT-6 skin test reagent by the Mantoux injection technique.

P. Andersen, K. Weldingh, V. Thomsen, 2009, Tuberculosis.

Evaluation of local toxicity after repeated intranasal vaccination of guinea-pigs.

G. Georgsson, S. Gizurarson, H. Aggerbeck, 1996, Toxicology.

The seroepidemiology of measles in Western Europe

France, Finland., J. Schellekens, 2001, Epidemiology and Infection.